The price of Clover Health Investments Corp. (NASDAQ:CLOV) shares last traded on Wall Street rose 0.73% to $1.38.
Based on available information, 6 analysts follow Clover Health Investments Corp. (NASDAQ:CLOV). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $3.00 and a low of $0.90, we find $1.50. Given the previous closing price of $1.37, this indicates a potential upside of 9.49 percent. CLOV stock price is now 22.15% away from the 50-day moving average and 29.81% away from the 200-day moving average. The market capitalization of the company currently stands at $674.45M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
Among analysts, 3 rate the stock a hold while 1 rate it a buy. Brokers who have rated the stock have averaged $1.65 as their price target over the next twelve months.
With the price target reduced from $7 to $3, Cowen Upgraded its rating from Underperform to Market Perform for Clover Health Investments Corp. (NASDAQ: CLOV).
Insiders disposed of 1,359,078 shares of company stock worth roughly $1.88 million over the past 1 year. A total of 3.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in CLOV stock. A new stake in Clover Health Investments Corp. shares was purchased by GMT CAPITAL CORP during the first quarter worth $1,801,000. CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. invested $1,094,000 in shares of CLOV during the first quarter. In the first quarter, Y-INTERCEPT (HONG KONG) LTD acquired a new stake in Clover Health Investments Corp. valued at approximately $537,000. POINT72 MIDDLE EAST FZE acquired a new stake in CLOV for approximately $520,000. XTX TOPCO LTD purchased a new stake in CLOV valued at around $374,000 in the second quarter. In total, there are 202 active investors with 32.50% ownership of the company’s stock.
A candlestick chart of Clover Health Investments Corp. (NASDAQ: CLOV) showed a price of $1.3700 on Wednesday morning. During the past 12 months, Clover Health Investments Corp. has had a low of $0.71 and a high of $2.78. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 1.20, and a quick ratio of 1.20. The fifty day moving average price for CLOV is $1.1403 and a two-hundred day moving average price translates $1.0630 for the stock.
The latest earnings results from Clover Health Investments Corp. (NASDAQ: CLOV) was released for Jun, 2023. According to the Healthcare Plans Company, earnings per share came in at -$0.06, beating analysts’ expectations of -$0.15 by 0.09. This compares to -$0.22 EPS in the same period last year. The net profit margin was -9.30% and return on equity was -74.40% for CLOV. The company reported revenue of $513.63 million for the quarter, compared to $846.7 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -39.34 percent. For the current quarter, analysts expect CLOV to generate $482.91M in revenue.
Clover Health Investments Corp.(CLOV) Company Profile
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. The company was incorporated in 2014 and is based in Franklin, Tennessee.
